Evatanepag
| Title | Journal |
|---|---|
| Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation. | Bioorganic & medicinal chemistry letters 20090401 |
| CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance. | Drug metabolism and disposition: the biological fate of chemicals 20081001 |
| In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP(4) receptor antagonist. | Life sciences 20080116 |
| Effects of gestational age on prostaglandin EP receptor expression and functional involvement during in vitro contraction of the guinea pig uterus. | Prostaglandins, leukotrienes, and essential fatty acids 20080101 |
| Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. | Drug metabolism and disposition: the biological fate of chemicals 20050801 |
| Prostaglandin E2 receptor subtype EP-2 is not involved in the induction of non-pregnant guinea pig uterine contractions associated with terminal pregnancy. | Prostaglandins, leukotrienes, and essential fatty acids 20041201 |
| A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20031101 |
| An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. | Proceedings of the National Academy of Sciences of the United States of America 20030527 |